Humanized Mouse And Rat Model Market Report
First published: 11 October 2024 | Last updated: 25 May 2026 | Report Code: humanized-mouse-and-rat-model
Humanized Mouse And Rat Model Market — USD 2.5 billion in 2023, Growing to USD 5.42B by 2033 at 7.8% CAGR
This report presents a comprehensive analysis of the humanized mouse and rat model market from 2023 to 2033, including market size, industry trends, regional insights, and competitive landscape, providing valuable data-driven insights for stakeholders and decision-makers.
Key Takeaways
- Global market expands from $2.50 Billion in 2023 to $5.42 Billion in 2033 with a 7.8% CAGR during 2023 to 2033.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- North America is the largest region, rising from $0.95 Billion in 2023 to $2.07 Billion in 2033.
- Europe moves from $0.65 Billion in 2023 to $1.42 Billion in 2033, reflecting sustained demand across research and pharma.
- Asia Pacific increases from $0.51 Billion in 2023 to $1.11 Billion in 2033 amid expanding biotech investment.
- Key suppliers and service providers include Charles River Laboratories, Jackson Laboratory, Envigo, Taconic Biosciences, and Cyagen Biosciences.
Humanized Mouse And Rat Model Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The market for humanized mouse and rat models is projected to grow from $2.50 Billion in 2023 to $5.42 Billion in 2033, reflecting a 7.8% CAGR over the 2023 to 2033 forecast period. Growth is supported by rising R&D investments from pharmaceutical companies, expanding academic research, and advances in genetic engineering and translational models. Commercial suppliers and research institutes are responding with enhanced product offerings and collaborative programs. Regional dynamics show North America as the largest market, while several regions exhibit notable expansion driven by biotech adoption and funding. Key end users include academic institutions, pharmaceutical companies, biotechnology firms, and contract research organizations. Leading vendors such as Charles River Laboratories and Jackson Laboratory play pivotal roles in supplying models and related services. The report examines segmentation across model types, applications, suppliers, and end users, and provides an evidence-based outlook grounded in expert interviews and documented sources.
Key Growth Drivers
- Increased R&D spending by pharmaceutical and biotech companies accelerating demand for translational animal models.
- Technological progress in genome editing and human immune system engraftment improving model relevance for drug development.
- Expanded use in precision medicine, gene therapy, and vaccine research prompting broader adoption across institutions.
- Collaborations between commercial suppliers and academic centers enhancing access and specialized model development.
- Rising prevalence of chronic and complex diseases driving needs for predictive preclinical platforms.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $2.50 Billion |
| CAGR (2023-2033) | 7.8% |
| 2033 Market Size | $5.42 Billion |
| Top Companies | Charles River Laboratories, Jackson Laboratory, Envigo, Taconic Biosciences, Cyagen Biosciences |
| Published Date | 11 October 2024 |
| Last Modified Date | 25 May 2026 |
Humanized Mouse And Rat Model Market Overview
Customize Humanized Mouse And Rat Model Market Report market research report
- ✔ Get in-depth analysis of Humanized Mouse And Rat Model market size, growth, and forecasts.
- ✔ Understand Humanized Mouse And Rat Model's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Humanized Mouse And Rat Model
What is the Market Size & CAGR of Humanized Mouse And Rat Model Market Report market in 2023?
Humanized Mouse And Rat Model Industry Analysis
Humanized Mouse And Rat Model Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Humanized Mouse And Rat Model Market Report Market Analysis Report by Region
Europe Humanized Mouse And Rat Model Market Report:
Europe grows from $0.65 Billion in 2023 to $1.42 Billion in 2033. Expansion reflects rising biotech investment, collaborative research programs, and demand from pharmaceutical and academic sectors for translational models.Asia Pacific Humanized Mouse And Rat Model Market Report:
Asia Pacific grows from $0.51 Billion in 2023 to $1.11 Billion in 2033. Regional drivers include expanding biotechnology funding, growing pharmaceutical research activities, and enhanced adoption of advanced preclinical models.North America Humanized Mouse And Rat Model Market Report:
North America is largest regional market, rising from $0.95 Billion in 2023 to $2.07 Billion in 2033. Growth here is supported by concentrated pharmaceutical R&D, strong commercial supplier presence, and extensive academic research infrastructure.South America Humanized Mouse And Rat Model Market Report:
Latin America grows from $0.23 Billion in 2023 to $0.5 Billion in 2033. Local growth is attributed to increasing research initiatives, rising healthcare research funding, and expanding collaborations with global suppliers.Middle East & Africa Humanized Mouse And Rat Model Market Report:
Middle East and Africa grows from $0.15 Billion in 2023 to $0.32 Billion in 2033. This growth is linked to developing research capacity, targeted investments in life sciences, and partnerships with commercial suppliers and institutes.Tell us your focus area and get a customized research report.
Research Methodology
Humanized Mouse And Rat Model Market Analysis By Model Type
The segmentation by model type reveals that humanized mice represent the majority share of the market, exhibiting a size growth from 2.11 billion USD in 2023 to 4.56 billion USD by 2033. Humanized rats, though smaller, are anticipated to grow from 0.40 billion USD to 0.86 billion USD within the same period.
Humanized Mouse And Rat Model Market Analysis By Application
The application segments showcase that pharmaceutical research constitutes the largest share, with a size increasing from 1.59 billion USD in 2023 to 3.44 billion USD in 2033. Gene therapy applications and vaccination studies represent niche markets, anticipated to grow significantly due to increasing focus on personalized medicine and immunotherapy.
Humanized Mouse And Rat Model Market Analysis By End User
Among end-users, academic institutions lead the market with a size of 1.33 billion USD in 2023, expected to reach 2.87 billion USD by 2033, indicating their pivotal role in research and development. Pharmaceutical companies follow closely, demonstrating significant growth as they leverage these models for drug discovery processes.
Humanized Mouse And Rat Model Market Analysis By Region
Research type segmentation shows that in vivo studies hold a significant market share, growing from 2.11 billion USD in 2023 to 4.56 billion USD in 2033. Ex vivo studies are also gaining traction, with an expected growth from 0.40 billion USD to 0.86 billion USD as their application expands in research.
Humanized Mouse And Rat Model Market Analysis By Supplier
Commercial suppliers are exploring ways to enhance the production and supply of humanized models. With growth projected from 0.40 billion USD to 0.86 billion USD by 2033, collaboration between suppliers and research institutions is crucial for advancing model authenticity and applicability.
Humanized Mouse And Rat Model Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Humanized Mouse And Rat Model Industry
Charles River Laboratories:
A leading provider of preclinical and clinical laboratory services, Charles River offers comprehensive drug development solutions including humanized animal models.Jackson Laboratory:
Specializes in genetics research and mouse models, ensuring the highest standards for humanized models used in academic and pharmaceutical research.Envigo:
Offers a wide range of laboratory animal models and services, focusing on delivering high-quality humanized models tailored for pharmaceutical applications.Taconic Biosciences:
Provides genetically engineered rodents and other model organisms, creating custom solutions for clients’ specific research needs.Cyagen Biosciences:
Develops and manufactures a variety of transgenic and knockout mouse models, contributing significantly to the growth of the humanized model market.We're grateful to work with incredible clients.
FAQs
What is the market size of the Humanized Mouse And Rat Model Market Report in 2023?
The market size in 2023 is $2.50 Billion, based on the reported data for the 2023 baseline year.
How big will the market be by 2033?
The market is projected to reach $5.42 Billion by 2033 according to the provided forecast figures.
What is CAGR for the forecast period?
The compound annual growth rate for the 2023 to 2033 forecast period is 7.8% as stated in the input data.
Is there a single fastest Growing region in the Humanized Mouse And Rat Model Market Report market?
No single fastest-growing region is stated for the Humanized Mouse And Rat Model Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which regions show notable growth by 2033?
Europe, Asia Pacific, Latin America, and Middle East and Africa all grow by 2033; their exact values are provided for comparative analysis.
Who are the leading companies listed for this market?
Top companies named include Charles River Laboratories, Jackson Laboratory, Envigo, Taconic Biosciences, and Cyagen Biosciences.
What end users are covered in the segmentation?
End users include academic institutions, pharmaceutical companies, biotechnology firms, and contract research organizations as specified.
How are model types categorized in the report?
Model types are specified as humanized mice and humanized rats within the segmentation details provided.
What applications are highlighted for these models?
Applications include pharmaceutical research, gene therapy, and vaccination studies according to the input segment facts.
Why is the fastest Growing region not named?
The regional growth market is Not specified because top regional growth rates are within 0.15 percentage points, per the provided policy.